Please try another search
For the fiscal year ended 31 December 2017, Haemato AG revenues increased 5% to EUR289.9M. Net income decreased 37% to EUR7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Other Operating Expenses increase of 6% to EUR8.9M (expense), Wages and Salaries increase of 3% to EUR5.2M (expense), Interest and Similar Expenses increase of 5% to EUR2M (expense).
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Revenue | 151.05 | 138.81 | 133.34 | 142.27 |
Gross Profit | 10.76 | 9.19 | 9.69 | 9.78 |
Operating Income | 6.23 | 3.18 | 7.51 | 5.93 |
Net Income | 4.82 | 2.16 | 6.55 | 4.49 |
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Total Assets | 122.03 | 119.76 | 116.77 | 120.03 |
Total Liabilities | 51.1 | 53.65 | 53.68 | 63.49 |
Total Equity | 70.93 | 66.11 | 63.09 | 56.54 |
Period Ending: | Dec 31, 2017 | Jun 30, 2017 | Dec 31, 2016 | Jun 30, 2016 |
---|---|---|---|---|
Period Length: | 12 Months | 6 Months | 12 Months | 6 Months |
Cash From Operating Activities | -8.35 | -3.81 | 12.75 | 0.88 |
Cash From Investing Activities | 5.44 | -0.07 | 0.05 | 1.28 |
Cash From Financing Activities | -0.41 | -0.97 | -5.46 | -2.77 |
Net Change in Cash | -3.32 | -4.85 | 7.34 | -0.6 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review